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PRE-PROCEDURAL PLANNING FOR INCREASINGLY COMPLEX TRANSCATHETER PROCEDURES
requires accurate and detailed understanding of cardiac anatomy. Echocardiography is widely used but
has limitations of interoperator variability (2-dimensional [2D] and 3-dimensional [3D]), wider anatomic
appreciation (2D), and suboptimal spatial and temporal resolution (3D). Multidetector computed to-
mography (MDCT) is an emerging diagnostic tool for structural heart disease intervention planning.
Electrocardiogram-gated spiral acquisition protocols using contrast renders anatomic detail at submilli-
meter level (1). Open-source software allows operators to visualize volume and surface rendered images
in 3D. Size, shape, and orientation of target lesions are identiﬁed accurately in relation to adjacent
anatomy, extra-cardiac structures, orientation of the great vessels, and origin of branch arteries.
MDCT is highly reproducible, with fast acquisition protocols, and complements information provided by
echocardiography and ﬂuoroscopy in the planning of complex transcatheter procedures. Limitations of
MDCT include exposure to radiation, the windowing effect, and the administration of a contrast medium
that may have implications in renal dysfunction. Clinical use of MDCT in treating mitral paravalvular leak
(Figs. 1 and 2), aortic paravalvular leak (Fig. 3), ventricular septal defect (Fig. 4), aortic pseudoaneurysm
(Fig. 5) and aortic graft endoleak (Fig. 6) are illustrated below.
Transesophageal echocardiography was performed using a Philips IE33 or CX50 ultrasound system
(Philips Healthcare, Best, the Netherlands). MDCT was performed using a Siemens SOMATOM Deﬁnition
Flash scanner (Siemens Healthcare, Erlangen, Germany). Multiplanar and 3D reconstructions were created
using Food and Drug Administration–approved DICOM (Digital Imaging and Communications in Medi-
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Figure 1. Mitral PVL Treated Using an Amplatzer Vascular Plug III
A 79-year-old man 5 months post-mitral valve replacement for severe mitral regurgitation presented with congestive cardiac failure. Initial transthoracic
echocardiography (TTE) revealed signiﬁcant mitral paravalvular leak (PVL) with moderate pulmonary hypertension. (A) Transesophageal echocardiography (TEE)
identiﬁed a well-localized PVL with no rocking of the valve. (B and C) Three-dimensional (3D) TEE surgical views from the left atrium demonstrated echocardiographic
dropout along the paravalvular space (red stars). Multidetector computed tomography (MDCT) was performed to further evaluate the size and position of the leak.
(D) Multiplanar reconstruction conﬁrmed a single crescent-shaped paravalvular dehiscence measuring 10 mm  4 mm along the posterior medial aspect of the
mitral valve (red star). (E) 3D reconstruction demonstrates contrast passing through the PVL (orange arrow). The patient underwent successful percutaneous closure
of the PVL using a 14 mm  5-mm Amplatzer Vascular Plug III device (off-label use) (St. Jude Medical, St. Paul, Minnesota) under real-time 3D TEE guidance.
(F) Multiplanar reconstruction shows the Amplatzer device optimally aligned to the mitral annulus along the paravalvular space (green arrow). (G) MDCT 3D
reconstruction shows the Amplatzer device in situ with trivial residual leak (green arrow).
Figure 2. Mitral PVL Closed Using 2 Amplatzer Vascular Plug III Devices
A 51-year-old man with a history of rheumatic heart disease and 3 previous mitral valve replacements developed a large PVL resulting in intravascular hemolysis
requiring blood transfusion. (A) TTE and (B) TEE revealed a high-velocity paraprosthetic leak from the posterior medial aspect of the mitral valve prosthesis. MDCT was
performed to further evaluate the size and position of the leak. (C and D) Multiplanar reconstruction showed a large crescentic area of valve dehiscence approximately
4 mm  6 mm (red arrows). (E) Two 14 mm  5-mm Amplatzer devices (off-label use) were used side by side to close the defect successfully (green arrows). (F)
Follow-up TEE performed 3 months post-closure showed a stable mitral valve with residual mild-to-moderate mitral regurgitation via a very small PVL anterior and
adjacent to the vascular plugs. (G) The closure devices appeared stable, straddling the valve annulus on 3D TEE. Abbreviations as in Figure 1.
Newland et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 7 , N O . 6 , 2 0 1 4
Emerging Role of Multidetector Cardiac Computed Tomography J U N E 2 0 1 4 : 6 2 7 – 3 1
628
Figure 3. Aortic Valve PVL Closed Using an Amplatzer Septal Occluder
A 41-year-old man with a past history of St. Jude Medical aortic valve replacement for bicuspid aortic valve incompetence presented 1 year later with increasing
breathlessness. Patient was anemic with evidence of intravascular hemolysis. (A) TEE revealed a stable aortic valve prosthesis with a moderate-to-severe PVL origi-
nating from the anatomic site of the left coronary cusp. Electrocardiogram-gated spiral computed tomography of the heart with contrast was performed to further
evaluate the leak. (B and C) Multiplanar reconstruction showed a crescent area of valve dehiscence approximately 14 mm  5 mm anterior and inferior to the left
coronary artery. He underwent successful PVL closure using a 6-mm Amplatzer Septal Occluder (off-label use). (D) Follow-up TEE revealed signiﬁcant improvement of
the paravalvular regurgitation. (E) 3D TEE showed the Amplatzer device (green arrow) in situ and optimal prosthetic valve function. (F and G) MDCT showing the
device straddling the aortic valve annulus (orange arrows). Abbreviations as in Figure 1.
Figure 4. VSD Following Perioperative STEMI Treated Using an Amplatzer VSD Occluder Device
A 76-year-old man had a perioperative ST-segment elevation myocardial infarction (STEMI) following elective spinal surgery. He developed acute pulmonary edema,
and emergency TTE conﬁrmed post-infarct ventricular septal defect (VSD). Despite initial conservative treatment using an intra-aortic balloon pump (IABP) and
inotropes, hemodynamic parameters deteriorated. He was deemed unsuitable for cardiac surgery, and the option of transcatheter treatment was explored. (A to C)
Multiplanar MDCT reconstruction conﬁrmed a posterior muscular septal defect measuring 16 mm  18 mm (red stars). (D) 3D reconstruction of the VSD in the
short axis (green arrow). (E) En face view of the VSD using 3D TEE viewed from the left ventricle. Percutaneous closure of the VSD using a 22-mm Amplatzer VSD
Occluder device under real-time 3D TEE guidance was performed. Hemodynamic parameters improved immediately, and the IABP was successfully removed. The
patient was discharged from cardiology 5 days later. (F and G) Post-procedure TEE showing the VSD device in situ (green arrow) with mild residual left-to-right shunt.
(H) 3D MDCT shows optimal alignment of the VSD device (green arrow). Abbreviations as in Figure 1.
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Figure 5. Treatment of an Aortic Pseudoaneurysm of a Bentall Graft Using an Amplatzer Device
A 45-year-old woman underwent a Bentall procedure with a single saphenous vein graft (SVG) to her left anterior descending coronary artery (LAD) for bicuspid aortic
valve stenosis and dilated aortic root. The SVG was attached proximally in the Dacron graft and to the mid-LAD. She presented to hospital 5 months later with severe
upper back pain. With initial investigations unhelpful, MDCT was performed. (A and B) Multiplanar reconstruction identiﬁed a large pseudoaneurysm (red stars)
arising anterior to the Bentall graft along the inferior margins of the SVG anastomosis site (green arrows). (C and D) 3D reconstructions render the pseudoaneurysm
and its relationship to the Bentall graft. Multiple reconstructions identiﬁed the neck of the pseudoaneurysm along the inferior margin of the SVG anastomotic site (blue
arrow). A 6-mm Amplatzer device (off-label use) was used to close the defect successfully. (E to G) MDCT post-procedure conﬁrmed complete occlusion of the
pseudoaneurysm and optimal position of the Amplatzer device in situ. MDCT ¼ multidetector computed tomography.
Figure 6. Endoleak of a Supracoronary Interposition Graft of the Ascending Aorta Treated Using an Amplatzer ASD Closure Device
A 79-year-old woman presented with breathlessness and chest pain. Past cardiac history includes insertion of a 28-mm supracoronary interposition graft of the
ascending aorta and a 19-mm St. Jude Medical subcoronary aortic valve replacement. Computed tomographic pulmonary angiography performed initially to exclude
pulmonary embolus identiﬁed an incidental endoleak. (A and B) Multiplanar reconstructions of arterial-phase MDCT with contrast show the endoleak (red star)
originating from the inferior anastomotic site of the aortic interposition graft 13 to 15 mm superior to the left main stem coronary artery (green arrow). (C) TEE
conﬁrmed both the aneurysm (red star) and its origin (green arrow). (D) 3D MDCT reconstruction showed lateral compression of the interposition graft by the
aneurysm with its origin inferiorly (orange arrow). A 6-mm Amplatzer ASD closure device (off-label use) was successfully deployed to close the defect. (E to G) MDCT
3 months post-procedure demonstrates the device (blue arrow) within the aneurysm origin, with no evidence of obstruction to the left main stem coronary artery.
(G) 3D reconstruction shows the Amplatzer device and the aneurysm containing mostly organized thrombus. Abbreviations as in Figure 1.
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